Financial Summary (All financials)
In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
Revenues | 75.2 | 61.6 | 48.8 | 32.5 | 17.6 |
Revenue growth | 22.1% | 26.1% | 50.0% | 85.3% | |
Cost of goods sold | 18.7 | 14.1 | 10.8 | 7.8 | 4.8 |
Gross profit | 56.5 | 47.5 | 38.1 | 24.7 | 12.8 |
Gross margin | 75.1% | 77.2% | 78.0% | 76.0% | 72.8% |
Sales and marketing | 56.8 | 44.9 | 32.8 | 27.6 | 21.6 |
Research and development | 7.8 | 5.4 | 4.3 | 5.1 | 5.9 |
General and administrative | 18.6 | 13.0 | 6.1 | 4.3 | 4.1 |
EBITA | -26.3 | -15.9 | -5.1 | -12.3 | -18.8 |
EBITA margin | -35.0% | -25.8% | -10.4% | -37.9% | -107.3% |
Amortization of intangibles | 0.4 | | | | |
EBIT | -26.7 | -15.9 | -5.1 | -12.3 | -18.8 |
EBIT margin | -35.5% | -25.8% | -10.4% | -37.9% | -107.3% |
Pre-tax income | -28.7 | -18.3 | -6.9 | -13.4 | -19.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -28.7 | -18.3 | -6.9 | -13.4 | -19.0 |
Net margin | -38.2% | -29.7% | -14.2% | -41.2% | -108.2% |
|
Diluted EPS | ($1.53) | ($1.06) | ($4.62) | ($11.82) | ($27.29) |
Shares outstanding (diluted) | 18.8 | 17.2 | 1.5 | 1.1 | 0.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|